224 related articles for article (PubMed ID: 9064975)
1. [Endothelial regulation of coronary circulation: current status].
Schächinger V; Zeiher AM
Z Kardiol; 1996; 85 Suppl 6():263-7. PubMed ID: 9064975
[TBL] [Abstract][Full Text] [Related]
2. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dysfunction in human disease.
Drexler H; Hornig B
J Mol Cell Cardiol; 1999 Jan; 31(1):51-60. PubMed ID: 10072715
[TBL] [Abstract][Full Text] [Related]
4. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
Zeiher AM; Schächinger V
Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
[TBL] [Abstract][Full Text] [Related]
5. [Endothelial function in coronary atherosclerosis and heart failure--the role of nitric oxide in regulation of vasomotor tone].
Andreassen AK; Kirkebøen KA
Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4066-9. PubMed ID: 10613099
[TBL] [Abstract][Full Text] [Related]
6. Flow-dependent vasodilation in the coronary circulation: alterations in diseased states.
Mandinov L; Kaufmann P; Maier W; Hess OM
Semin Interv Cardiol; 1998 Mar; 3(1):5-12. PubMed ID: 10094179
[TBL] [Abstract][Full Text] [Related]
7. Coronary endothelial cells: a target of ischemia reperfusion and its treatment?
Laude K; Richard V; Thuillez C
Arch Mal Coeur Vaiss; 2004 Mar; 97(3):250-4. PubMed ID: 15106748
[TBL] [Abstract][Full Text] [Related]
8. [Coronary vasomotion in coronary heart disease--significance of epicardial and microcirculatory vessels for myocardial perfusion].
Kelm M; Schäfer S; Preik M; Schoebel FC; Preik-Steinhoff H; Strauer BE
Z Kardiol; 1997; 86 Suppl 1():33-41. PubMed ID: 9173720
[TBL] [Abstract][Full Text] [Related]
9. Endothelium dysfunction in the coronary circulation.
Lüscher TF; Noll G
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
Tschudi MR; Noll G; Lüscher TP
Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
[TBL] [Abstract][Full Text] [Related]
11. Exercise and the coronary circulation-alterations and adaptations in coronary artery disease.
Linke A; Erbs S; Hambrecht R
Prog Cardiovasc Dis; 2006; 48(4):270-84. PubMed ID: 16517248
[TBL] [Abstract][Full Text] [Related]
12. The endothelium in acute coronary syndromes.
Noll G; Lüscher TF
Eur Heart J; 1998 Apr; 19 Suppl C():C30-8. PubMed ID: 9597423
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerosis-associated endothelial dysfunction.
Schächinger V; Zeiher AM
Z Kardiol; 2000; 89 Suppl 9():IX/70-4. PubMed ID: 11151799
[TBL] [Abstract][Full Text] [Related]
14. [Endothelial dysfunction and coronary heart disease. Interaction of endothelium and thrombocytes].
Vanhoutte PM
Schweiz Rundsch Med Prax; 1993 Oct; 82(42):1161-6. PubMed ID: 8248687
[TBL] [Abstract][Full Text] [Related]
15. [The mechanism of action of nitrates, 1988 status].
Lichtlen PR
Z Kardiol; 1989; 78 Suppl 2():3-10; discussion 64-7. PubMed ID: 2511690
[TBL] [Abstract][Full Text] [Related]
16. [Coronary microangiopathy in hypertensive heart disease: pathogenesis, diagnosis and therapy].
Motz W; Scheler S; Strauer BE
Herz; 1995 Dec; 20(6):355-64. PubMed ID: 8582695
[TBL] [Abstract][Full Text] [Related]
17. Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning.
Pagliaro P; Chiribiri A; Mancardi D; Rastaldo R; Gattullo D; Losano G
Ital Heart J; 2003 Jun; 4(6):383-94. PubMed ID: 12898803
[TBL] [Abstract][Full Text] [Related]
18. The sympathetic nervous system and ischaemic heart disease.
Remme WJ
Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
[TBL] [Abstract][Full Text] [Related]
19. [The coronary circulation and myocardial ischemia].
Hoffmann E; Sclafani R
Ital Heart J; 2000 Jun; 1 Suppl 2():7-12. PubMed ID: 10905122
[TBL] [Abstract][Full Text] [Related]
20. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.
Boodhwani M; Nakai Y; Voisine P; Feng J; Li J; Mieno S; Ramlawi B; Bianchi C; Laham R; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I402-8. PubMed ID: 16820608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
